دورية أكاديمية

Anti-carbamylated protein antibodies positivity and disease activity in Hispanic patients with established rheumatoid arthritis: An observational study.

التفاصيل البيبلوغرافية
العنوان: Anti-carbamylated protein antibodies positivity and disease activity in Hispanic patients with established rheumatoid arthritis: An observational study.
المؤلفون: Vega-Morales, David, Garza-Elizondo, Mario A., Trouw, Leendert A., Gonzalez-Torres, Karina I., Torres-Lopez, Ernesto, Eguia-Bernal, Miryam, Loredo-Alanis, Salvador A., Gracia-Arechiga, Tayde S., Vazquez-Fuentes, Brenda R., Castañeda-Martinez, Diana D., Castañda-Martinez, Martha M., Elizondo-Solis, Cesar V., Mendiola-Jimenez, Andres, Salinas-Carmona, Mario C., Herrera-Sandate, Pablo, Cardenas-de la Garza, Jesus A., Rodriguez-Sanchez, Gerardo E., Galarza-Delgado, Dionicio A.
المصدر: Modern Rheumatology; Mar2022, Vol. 32 Issue 2, p330-337, 8p
مستخلص: Objectives: We aimed to determine the prevalence of anti-carbamylated protein (anti-CarP) antibodies in Mexican Hispanics with established rheumatoid arthritis (RA) and to assess their relationship with disease activity. Methods: A cohort study was conducted in 278 patients with established RA during an 18-month follow-up. We measured IgG/IgM/IgA rheumatoid factor (RF), IgG anticitrullinated protein antibodies (ACPA) and IgG/IgM/IgA anti-CarP antibodies using enzyme-linked immunosorbent assay (ELISA). For disease activity, we performed the 28-joint disease activity score with erythrocyte sedimentation rate (DAS28-ESR). Repeated measures one-way ANOVA was used to test the association between anti-CarP IgG antibody status and longitudinal DAS28-ESR scores. Patients were evaluated at baseline and at 6, 12, and 18 months during follow-up. Results: Anti-CarP IgG antibodies were positive in 47.8% of patients and, accounting for all isotypes, in 9.5% of patients with negative RF and ACPA. Triple antibody positivity was present in 42.6% of patients in our sample. Anti-CarP IgG antibody positivity did not show statistically significant differences in mean DAS28-ESR when compared to anti-CarP IgG antibody negative patients at baseline, 6, 12 or 18 months. Conclusion: Anti-CarP IgG antibodies are not associated to a higher disease activity in Hispanic patients with established RA. Our findings suggest that the clinical value of measuring anti-CarP anti-bodies in RA diminishes over time. [ABSTRACT FROM AUTHOR]
Copyright of Modern Rheumatology is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:14397595
DOI:10.1080/14397595.2021.1913277